Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Follicular unit extraction successfully restored hair growth in a leprosy patient without disease relapse.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The cat died from a hard-to-treat fungal infection despite various treatments.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

A child with Sweet syndrome was found to have chronic granulomatous disease and improved with treatment.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Hair loss in a child was an early sign of Crohn's disease.

Hair loss can be an early sign of Crohn's disease in children.

Transgender acne treatment requires a tailored approach with ongoing topical treatments and ceramide-rich moisturizers.